Balloon Catheters Market Report 2025

This Balloon Catheters market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The balloon catheters market size has grown strongly in recent years. It will grow from $3.92 billion in 2024 to $4.14 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth observed during the historical period can be attributed to several factors, including a greater emphasis on chronic disease management, the rising prevalence of cardiovascular diseases, an increased focus on patient-centered care, a growing geriatric population, and a higher demand for improved catheter performance.

The balloon catheters market size is expected to see strong growth in the next few years. It will grow to $5.08 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth expected during the forecast period can be attributed to factors such as increased healthcare spending, the rise of endovascular procedures, more research and development activities, the growing use of balloon catheters in non-cardiac applications, and the expansion of healthcare access in emerging markets. Key trends for this period include balloon-assisted stent deployment, enhanced inflation mechanisms, customization with advanced imaging, and the integration of wearable and remote monitoring devices.

The growing preference for minimally invasive surgeries is anticipated to drive the expansion of the balloon catheters market. Minimally invasive surgeries (MIS) involve procedures that require smaller incisions, reducing the need for large cuts or openings in the body. The rise in MIS is attributed to benefits such as faster recovery, fewer complications, and less pain, supported by technological advancements and the popularity of outpatient procedures. Balloon catheters are essential in enhancing the effectiveness of MIS by improving precision, safety, and patient comfort, while also reducing recovery times and hospital stays. For example, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported a 12% increase in the placement of their da Vinci surgical systems in the fourth quarter of 2023 compared to 2022, highlighting the growing adoption of minimally invasive techniques. As a result, the increased use of minimally invasive surgeries is boosting the balloon catheters market.

Key players in the balloon catheters market are concentrating on the development of mechanical thrombectomy (MT) solutions to enhance the effectiveness of blood clot removal by controlling blood flow during these procedures. Mechanical thrombectomy (MT) is a minimally invasive technique used to extract blood clots from blood vessels, primarily in cases of ischemic stroke. For example, in September 2024, CERENOVUS, a neurovascular division of Johnson & Johnson Medical Devices, introduced the EMBOGUARD Balloon Guide Catheter in Europe. This device is intended for endovascular treatments, including the management of acute ischemic stroke. The EMBOGUARD catheter improves clot removal by precisely controlling blood flow during mechanical thrombectomy. Its application has shown to boost first-pass recanalization rates, shorten procedure times, and lower the chances of clot fragments causing new embolic events, which can result in additional ischemic issues. The EMBOGUARD Balloon Guide Catheter is part of CERENOVUS’s Stroke Solutions portfolio, a collection of tools designed to aid healthcare providers during mechanical thrombectomy interventions.

In September 2024, Quasar Medical, a contract development and manufacturing organization based in China, acquired Ridgeback Technologies for an undisclosed amount. The acquisition is part of Quasar's strategy to enhance its capacity to provide tailored balloon catheter solutions, streamline production processes, and reduce time-to-market. Additionally, it will help expand its presence into Galway, Ireland, solidifying its position in the minimally invasive device manufacturing sector. Ridgeback Technologies, based in Ireland, specializes in providing catheter balloons for the healthcare industry.

Major players in the balloon catheters market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Cook Medical Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Asahi Intecc Co. Ltd., Freudenberg Medical LLC, Biomerics, AngioDynamics Inc., Endologix Inc., Raumedic AG, Otsuka Pharmaceutical Factory Inc., AngioScore Inc., CardioFlow, Endocor GmbH, MicroPort Scientific Corporation, Eureka Medical Inc., and Neovasc Inc.

North America was the largest region in the balloon catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in balloon catheter report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Balloon catheters are medical devices commonly used in minimally invasive surgeries. These devices consist of a small, flexible tube with an inflatable balloon at the end. They are primarily used to treat narrowed or blocked blood vessels, such as in angioplasty procedures, where the balloon is inflated to expand or reopen constricted areas within blood vessels.

The primary types of balloon catheters include percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, chronic total occlusion (CTO) balloon catheters, and microcatheters. PTCA balloon catheters are specifically designed for the percutaneous transluminal coronary angioplasty (PTCA) procedure. This category includes various subtypes, such as normal balloon catheters, drug-eluting balloon catheters, cutting balloon catheters, stent graft balloon catheters, and scoring balloon catheters. These devices are distributed through direct tender, third-party distribution, and other channels. They are used in the treatment of coronary artery disease, peripheral artery disease, and other conditions, and are commonly utilized in hospitals, specialty centers, ambulatory surgery centers, and other healthcare facilities.

The balloon catheters market research report is one of a series of new reports that provides balloon catheters market statistics, including balloon catheters industry global market size, regional shares, competitors with a balloon catheters market share, detailed balloon catheters market segments, market trends and opportunities, and any further data you may need to thrive in the balloon catheters industry. This balloon catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The balloon catheter market consists of sales of non-compliant balloon catheters, high-pressure balloon catheters, biliary balloon catheters and urological balloon catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.